Valmark Advisers, Inc. Abb Vie Inc. Transaction History

Valmark Advisers, Inc.

$6.34 Billion
Q3 2024

A detailed history of Valmark Advisers, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Valmark Advisers, Inc. holds 7,483 shares of ABBV stock, worth $1.31 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

7,483

Previous 6,593 13.5%

Holding current value

$1.31 Million

Previous $1.13 Million 30.71%

% of portfolio

0.02%

Previous 0.02%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	BUY	$163.84 - $199.33 $145,817 - $177,403	890 Added 13.5%	7,483 $1.48 Million
Q2 2024 Jul 31, 2024	BUY	$154.79 - $180.76 $62,225 - $72,665	402 Added 6.49%	6,593 $1.13 Million
Q1 2024 May 03, 2024	SELL	$159.82 - $182.1 $19,977 - $22,762	-125 Reduced 1.98%	6,191 $1.13 Million
Q4 2023 Feb 02, 2024	SELL	$137.6 - $154.97 $72,377 - $81,514	-526 Reduced 7.69%	6,316 $978,000
Q3 2023 Nov 07, 2023	BUY	$133.59 - $154.65 $58,378 - $67,582	437 Added 6.82%	6,842 $1.02 Million
Q2 2023 Aug 02, 2023	SELL	$132.51 - $164.9 $7,553 - $9,399	-57 Reduced 0.88%	6,405 $862,000
Q1 2023 May 01, 2023	BUY	$144.61 - $166.54 $90,092 - $103,754	623 Added 10.67%	6,462 $1.03 Million
Q4 2022 Feb 06, 2023	SELL	$138.31 - $165.87 $8,298 - $9,952	-60 Reduced 1.02%	5,839 $944,000
Q3 2022 Nov 02, 2022	BUY	$134.21 - $153.93 $25,634 - $29,400	191 Added 3.35%	5,899 $792,000
Q2 2022 Aug 01, 2022	BUY	$137.62 - $174.96 $52,433 - $66,659	381 Added 7.15%	5,708 $874,000
Q1 2022 May 10, 2022	BUY	$131.98 - $163.75 $308,305 - $382,520	2,336 Added 78.1%	5,327 $864,000
Q4 2021 Feb 02, 2022	BUY	$107.43 - $135.93 $22,345 - $28,273	208 Added 7.47%	2,991 $405,000
Q3 2021 Nov 09, 2021	SELL	$106.4 - $120.78 $46,071 - $52,297	-433 Reduced 13.46%	2,783 $300,000
Q2 2021 Aug 06, 2021	BUY	$105.21 - $117.21 $38,612 - $43,016	367 Added 12.88%	3,216 $362,000
Q1 2021 May 04, 2021	BUY	$102.3 - $112.62 $64,244 - $70,725	628 Added 28.28%	2,849 $308,000
Q4 2020 Feb 03, 2021	BUY	$80.49 - $108.67 $178,768 - $241,356	2,221 New	2,221 $238,000
Q4 2019 Jan 31, 2020	SELL	$72.13 - $90.25 $381,423 - $477,242	-5,288 Closed	0 $0
Q3 2019 Nov 06, 2019	BUY	$62.98 - $75.72 $16,437 - $19,762	261 Added 5.19%	5,288 $400,000
Q2 2019 Aug 07, 2019	BUY	$65.7 - $83.98 $197 - $251	3 Added 0.06%	5,027 $366,000
Q1 2019 May 10, 2019	BUY	$77.14 - $90.79 $173,410 - $204,095	2,248 Added 80.98%	5,024 $405,000
Q4 2018 Feb 07, 2019	BUY	$77.85 - $96.01 $2,257 - $2,784	29 Added 1.06%	2,776 $256,000
Q3 2018 Nov 02, 2018	BUY	$88.91 - $98.84 $177 - $197	2 Added 0.07%	2,747 $260,000
Q2 2018 Aug 07, 2018	BUY	$89.78 - $106.23 $6,643 - $7,861	74 Added 2.77%	2,745 $254,000
Q1 2018 May 07, 2018	SELL	$92.01 - $123.21 $736 - $985	-8 Reduced 0.3%	2,671 $253,000
Q4 2017 Feb 09, 2018	BUY	$89.56 - $98.21 $239,931 - $263,104	2,679	2,679 $259,000

Others Institutions Holding ABBV

# of Institutions

3,855

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Valmark Advisers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Valmark Advisers, Inc. with notifications on news.

Account

Valmark Advisers, Inc. Abb Vie Inc. Transaction History